Coronavirus (COVID-19) and Managing the Risks to Your Organization

<strong><a style="font-size: 1.4rem; letter-spacing: 0.04rem; line-height: 1.28571;" class="u-cta u-primary-i u-td-none p-6" href="~/link.aspx?_id=D8F5FB12-52B8-4A55-AD49-3118A63EA3EC&_z=z"">COVID-19 Resource Center</a> </strong> <br>M&A and Transactions Advisory

Explore Home

As the COVID-19 outbreak continues to evolve, organizations are navigating the various stages of the M&A and transaction lifecycle to maximize their value. Whether acting as a buy- or sell-side participant, Kroll has a proven track record helping clients identify and investigate potential problems and assess the various financial and operational strategies available through every stage of a deal. Our team of experts is ready to assist and provide sound advice on distressed M&A, cash availability analysis, comprehensive due diligence, fairness opinions, disputes and restructuring considerations, among others.

Learn more about our COVID-19 risk management solutions.

M&A and Transactions Advisory
European Mid-Market Debt Update - Spring 2021
Private Capital Markets - Debt Advisory

European Mid-Market Debt Update - Spring 2021

March 31, 2021
European Mid-Market Debt Update – Spring 2021
Healthcare Services Sector Update - January 2021
M&A Advisory

Healthcare Services Sector Update - January 2021

February 22, 2021

by Brooks Dexter, Eric Coburn

Healthcare Services Sector Update – July 2019
M&A Advisory

Kroll Institute Fellow Efraim Chalamish shares timely insights on the deal and sector landscape in Israel, as well as equity capital markets activity and the impact of SPACs in the region.

December 15, 2020
European Chemicals Update - Q4 2020
M&A Advisory

European Chemicals Update - Q4 2020

November 27, 2020

by Andreas Stoecklin, Philipp Bose, Dafydd Evans, Paul Teuten, Javier Zoido, Jacques Giard, David Althoff, Stephen Burt, Howard Johnson, David Lu, Katsumi Asai

European Chemicals Update – Q4 2020
Dow Jones Industrial Average Special Report
M&A Advisory

Dow Jones Industrial Average Special Report

August 27, 2020

by Bob Bartell, CFA, Chris Janssen, Stephen Burt, Josh Benn, Jeff Schiedemeyer, Andreas Stoecklin, David Lu

Dow Jones Industrial Average Special Report
Canadian M&A Insights - Summer 2020
M&A Advisory

Canadian M&A Insights - Summer 2020

August 13, 2020

by Howard Johnson

Canadian M&A Insights – Summer 2020
Automotive Industry insights - Summer 2020
M&A Advisory

Automotive Industry insights - Summer 2020

July 24, 2020

by Mark Kwilosz, Stephen Burt, David Althoff, Victor Caruso, Howard Johnson, Andreas Stoecklin, Paul Teuten, David Lu, Katsumi Asai

Automotive Industry insights – Summer 2020
Staffing Industry Insights - Summer 2020
M&A Advisory

Staffing Industry Insights - Summer 2020

July 14, 2020

by James Rebello, Ham Crawford

Staffing Industry Insights - Winter 2019
Stay Ahead with Kroll

Mergers and Acquisitions (M&A) Advisory

Kroll’s investment banking practice has extensive experience in M&A deal strategy and structuring, capital raising, transaction advisory services and financial sponsor coverage.

Mergers and Acquisitions (M&A) Advisory

Distressed M&A and Special Situations

Kroll professionals have advised hundreds of companies, investors and other stakeholders at all stages of distressed transactions and special situations.

Distressed M&A and Special Situations

Kroll is headquartered in New York with offices around the world.

One World Trade Center
285 Fulton Street, 31st Floor
New York NY 10007
+1 212 593 1000
Sign up to receive periodic news, reports, and invitations from Kroll. Our privacy policy describes how your data will be processed.

More About Kroll

More About Kroll
© 2025 Kroll, LLC. All rights reserved. Kroll is not affiliated with Kroll Bond Rating Agency, Kroll OnTrack Inc. or their affiliated businesses. Read more.
Return to top